Neurological disorders are biologically diverse, making diagnosis, patient selection, and treatment response difficult to predict.
R&D Focus
Diagnostic-Powered Therapeutics for Brain Health
Innovative Solution
Gryphon Bio is a clinical stage company created to harness our co-founders’ discovery, over more than 20 years of -omic research, of unexpected waves of 1000s of brain molecules in the blood. The levels of brain-specific molecules in the blood change over time, like waves in the ocean, and can serve as biomarkers for novel blood tests of brain health. -Mission: To develop and market novel blood tests for brain health.
Investment Funding
Last Funding Stage
Grant
Total Funding Amount
14.37M
Last Funding Amount
6.67M
Last Funding Date
29-10-2023
Revenue
Less than $1M
People
Founders
Kevin Wang
PhD
Will Haskins
PhD
About
Gryphon Bio is a clinical stage company created to harness our co-founders’ discovery, over more than 20 years of -omic research, of unexpected waves of 1000s of brain molecules in the blood. The levels of brain-specific molecules in the blood change over time, like waves in the ocean, and can serve as biomarkers for novel blood tests of brain health. ​Mission: To develop and market novel blood tests for brain health. Vision: To pioneer novel blood tests to improve the lives of patients.
Something missing or incorrect on this page? Help us enrich this information
